Suzanne Schubbert
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
- Immunology top 5%
- Galectins and Cancer Biology
Papers in
-
- Protein Tyrosine Phosphatases 12
- PI3K/AKT/mTOR signaling in cancer 7
- RNA modifications and cancer 3
- Immunology 13
- Galectins and Cancer Biology 8
- Immune Cell Function and Interaction 4
- Co-authors
- Kevin Shannon (12 shared papers)Gideon Bollag (7 shared papers)Christian P. Kratz (4 shared papers)Charlotte M. Niemeyer (4 shared papers)Martin Zenker (4 shared papers)Hoa Nguyen (3 shared papers)Kam Y. J. Zhang (1 shared paper)Anita Rauch (1 shared paper)
- Journals
- Blood (5 papers)Cancer Research (4 papers)Nature reviews. Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Genetics (1 paper)
- Partner nations
- United StatesGermanyNorway
In The Last Decade
Suzanne Schubbert
21 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 736
- Immunology 540
- Molecular Biology 1.7k
- Hematology 188
- Cancer Research 223
Countries citing papers authored by Suzanne Schubbert
This map shows the geographic impact of Suzanne Schubbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Schubbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Schubbert more than expected).
Fields of papers citing papers by Suzanne Schubbert
This network shows the impact of papers produced by Suzanne Schubbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Schubbert. The network helps show where Suzanne Schubbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Schubbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperactive Ras in developmental disorders and cancer Hit paper breakdown → | 2007 | 1192 |
| 2 | Germline KRAS mutations cause Noonan syndrome Hit paper breakdown → | 2006 | 514 |
| 3 | 2005 | 114 | |
| 4 | 2007 | 89 | |
| 5 | 2007 | 70 | |
| 6 | 2011 | 61 | |
| 7 | 2006 | 44 | |
| 8 | 2014 | 38 | |
| 9 | 2007 | 38 | |
| 10 | 2015 | 23 | |
| 11 | 2007 | 21 | |
| 12 | 2015 | 13 | |
| 13 | 2017 | 11 | |
| 14 | 2018 | 10 | |
| 15 | 2007 | 9 | |
| 16 | 2024 | 5 | |
| 17 | 2009 | 5 | |
| 18 | 2004 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2018 | 3 |
About Suzanne Schubbert
Suzanne Schubbert is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (12 papers), Galectins and Cancer Biology (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), RNA modifications and cancer (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Oncology (736 citations), Immunology (540 citations), Molecular Biology (1.7k citations), Hematology (188 citations) and Cancer Research (223 citations). Suzanne Schubbert has collaborated with scholars based in United States, Germany and Norway. Frequent co-authors include Kevin Shannon, Gideon Bollag, Christian P. Kratz, Charlotte M. Niemeyer, Martin Zenker, Hoa Nguyen, Kam Y. J. Zhang, Anita Rauch, Silke Böll and Brian L. West. Their work appears in journals such as Blood, Cancer Research, Nature reviews. Cancer, Molecular Cancer Therapeutics and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.